Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Global Oncology"
DOI: 10.1200/jgo.18.73500
Abstract: Background and context: Several studies showed that the use of the recombinant monoclonal antibody trastuzumab, in addition to adjuvant chemotherapy, for breast cancer with overexpression of the HER-2 protein or amplification of the HER-2/neu gene…
read more here.
Keywords:
burden positive;
positive patients;
africa caregiver;
patients sub ... See more keywords